| Dr Orly P Steinberg, MD | |
|
15808 Mill Creek Blvd, Suite 200, Mill Creek, WA 98012-1500 | |
| (425) 673-3420 | |
| (425) 673-3423 |
| Full Name | Dr Orly P Steinberg |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 15808 Mill Creek Blvd, Mill Creek, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407812506 | NPI | - | NPPES |
| 7133770 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD00038311 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services- Washington | 8325100480 | 420 |
News Archive
In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy (CALD) - a neurodegenerative disease that typically claims young boys' lives within 10 years of diagnosis - effectively stabilized the disease's progression in 88 percent of patients, researchers from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Massachusetts General Hospital report today.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
TapImmune, Inc., a clinical stage immunotherapy company, specializing in the development of innovative technologies for the treatment of metastatic cancer, announced today the successful conveyance of the Mayo Clinic IND (Investigational New Drug Application) to TapImmune as part of the recently completed licensing agreement.
Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis. This is a type of cell death that plays a crucial role in numerous diseases, from viral infections and loss of auditory nerve cells to multiple sclerosis, acute heart failure and organ transplantation.
› Verified 9 days ago
| Entity Name | Obstetrix Medical Group Of Washington Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861599573 PECOS PAC ID: 3577451947 Enrollment ID: O20040308000679 |
News Archive
In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy (CALD) - a neurodegenerative disease that typically claims young boys' lives within 10 years of diagnosis - effectively stabilized the disease's progression in 88 percent of patients, researchers from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Massachusetts General Hospital report today.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
TapImmune, Inc., a clinical stage immunotherapy company, specializing in the development of innovative technologies for the treatment of metastatic cancer, announced today the successful conveyance of the Mayo Clinic IND (Investigational New Drug Application) to TapImmune as part of the recently completed licensing agreement.
Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis. This is a type of cell death that plays a crucial role in numerous diseases, from viral infections and loss of auditory nerve cells to multiple sclerosis, acute heart failure and organ transplantation.
› Verified 9 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy (CALD) - a neurodegenerative disease that typically claims young boys' lives within 10 years of diagnosis - effectively stabilized the disease's progression in 88 percent of patients, researchers from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Massachusetts General Hospital report today.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
TapImmune, Inc., a clinical stage immunotherapy company, specializing in the development of innovative technologies for the treatment of metastatic cancer, announced today the successful conveyance of the Mayo Clinic IND (Investigational New Drug Application) to TapImmune as part of the recently completed licensing agreement.
Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis. This is a type of cell death that plays a crucial role in numerous diseases, from viral infections and loss of auditory nerve cells to multiple sclerosis, acute heart failure and organ transplantation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Orly P Steinberg, MD 15808 Mill Creek Blvd, Suite 200, Mill Creek, WA 98012-1500 Ph: (425) 673-3420 | Dr Orly P Steinberg, MD 15808 Mill Creek Blvd, Suite 200, Mill Creek, WA 98012-1500 Ph: (425) 673-3420 |
News Archive
In a recent clinical trial, a gene therapy to treat cerebral adrenoleukodystrophy (CALD) - a neurodegenerative disease that typically claims young boys' lives within 10 years of diagnosis - effectively stabilized the disease's progression in 88 percent of patients, researchers from the Dana-Farber/Boston Children's Cancer and Blood Disorders Center and Massachusetts General Hospital report today.
Allos Therapeutics, Inc. announced today that the Agreement and Plan of Merger and Reorganization entered into by and among Allos, AMAG and Alamo Acquisition Sub, Inc. on July 19, 2011, as amended on August 8, 2011, has been terminated.
TapImmune, Inc., a clinical stage immunotherapy company, specializing in the development of innovative technologies for the treatment of metastatic cancer, announced today the successful conveyance of the Mayo Clinic IND (Investigational New Drug Application) to TapImmune as part of the recently completed licensing agreement.
Researchers at VIB and Ghent University have unraveled the mechanism of necroptosis. This is a type of cell death that plays a crucial role in numerous diseases, from viral infections and loss of auditory nerve cells to multiple sclerosis, acute heart failure and organ transplantation.
› Verified 9 days ago
Christine Koo, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 15418 Main St, Mill Creek, WA 98012 Phone: 425-225-8003 |